Journal for ImmunoTherapy of Cancer (Nov 2023)
466 Combined inhibition of KRAS G12C and PD-1 boosts the therapeutic efficacy via conditioning of tumor microenvironment in pre-clinical humanized NSCLC mouse models
Abstract
No abstracts available.
Journal for ImmunoTherapy of Cancer (Nov 2023)